MLAB 1415- Hematology
Keri Brophy-MartinezChapter 26: Lymphoid Malignancies: Chronic Lymphoid Leukemias
LymphomasPlasma Cell Neoplasms
Introduction
Divided into four categories based on maturity of neoplastic cells and distribution of disease
Acute lymphoblastic leukemia Proliferation of blasts belonging to lymphoid lineage
Chronic leukemic lymphoid malignancies Mature lymphocytes, insidious onset, indolent course
Malignant lymphoma Tumor masses involving lymphoid organs
Plasma cell neoplasms Involvement of immunoglobulin-secreting cells
Pathogenesis
Acquired genetic factors Proto-oncogenes Tumor suppressor genes
Inherited genetic factors Wiskott Aldrich Ataxia telangiectasia
Environmental factors EBV infection Helicobacter pylori
Chronic Lymphocytic Leukemia General requirements for diagnosis
Peripheral blood (>5000 ALC) and bone marrow lymphocytosis (>30%)
Lymphocytes are small to slightly larger than normal with mature appearance Nucleus is round, with block-type chromatin Cytoplasm scarce
Smudge cells (bare nuclei) are common Occur due to the cell’s fragility in making a smear
Prolymphocyte < 10%
CLL Blood Picture
Chronic Lymphocytic Leukemia Clinical features
Occurs in persons >50 years old Men are affected more than women 2:1 Chronic fatigue, infection
Result of bone marrow replacement of normal cells with lymphocytes.
Skin and organ infiltration and enlargement Median survival is 4-5 years, with 30% of patients
surviving 10 years
Chronic Lymphocytic Leukemia Treatment
Usually treatment is not required until lymphocytosis causes other cells to be crowded out resulting in infections.
Treatment depends on the stage at which the disease is diagnosed and is usually for the symptoms, not the disease. Radiation of localized infiltration Chemotherapy given according to stage of disease IV gamma globulin for prevention of infection Bone marrow transplant done on aggressive cases
Hairy cell leukemia (HCL)
Presents in middle age
Affects males7:1 over females
Pancytopenia common Increases opportunity for infections
Bone marrow aspirate can result in a “dry tap” due to marrow fibrosis.
Hairy cell leukemia can be treated with a one-time chemotherapy regimen with a good prognosis of long-term survival.
Hairy cell
TRAP stain
T cell Neoplasms
Large Granular Lymphocyte Leukemia Sezary’s Syndrome
Large Granular Lymphocyte Leukemia (LGLL) Moderate lymphocytosis Abundant pale blue
cytoplasm Azurophilic granules Clumped chromatin in
nuclei Anemia Neutropenia Thrombocytopenia
Sezary’s syndrome
Leukemic phase of the most common cutaneous T-cell lymphoma, mycosis fungoides.
Diagnosis is confirmed by skin biopsy and presence of Sézary cells.
Sezary Cell
References
• McKenzie, S. B., & Williams, J. L. (2010). Clinical Laboratory Hematology . Upper Saddle River: Pearson Education, Inc.
• http://www.med-ed.virginia.edu/courses/path/innes/wcd/lympleuk.cfm